DarioHealth Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DarioHealth Corp. on October 3, 2022. The filing announces the scheduling of the Company's 2022 Annual Meeting of Stockholders and establishes revised deadlines for shareholder proposals and director nominations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and meeting logistics rather than financial performance.
Material Changes
Due to the 2022 Annual Meeting date differing by more than thirty days from the anniversary of the 2021 Annual Meeting, the standard deadlines for shareholder proposals under Rule 14a-8 and director nominations are no longer applicable. The Company has established new, specific deadlines for these submissions.
Guidance, Outlook, and Management Commentary
- Meeting Date: Wednesday, December 7, 2022, at 4:00 p.m. Israel time.
- Location: 8 HaTokhen Street, Caesarea Industrial Park, Israel, 3088900.
- Record Date: Close of business on Thursday, October 13, 2022.
- Proposal Deadline: Stockholder proposals for inclusion in proxy materials must be received by the close of business on October 13, 2022.
- Submission Contact: Proposals should be sent to Zvi Ben-David, Chief Financial Officer, at 18 W. 18th St., 5th Floor, New York, New York 10011, or via email to ir@dariohealth.com.
Investor Verification Checklist
- Verify the record date of October 13, 2022, to determine eligibility to vote at the December 7, 2022, Annual Meeting.
- Confirm the October 13, 2022, deadline for submitting shareholder proposals or director nominations to ensure timely inclusion in proxy materials.
- Review the Company's amended and restated bylaws for specific requirements regarding the content and format of proposals.
- Note that the meeting will be held in Israel, which may impact attendance logistics for non-local shareholders.